<DOC>
	<DOCNO>NCT00396136</DOCNO>
	<brief_summary>The objective post approval registry confirm long-term safety effectiveness Corox Over-the-wire ( OTW ) Steroid Left Ventricular ( LV ) lead use conjunction BIOTRONK cardiac resynchronization therapy defibrillator ( CRT-D ) . The Corox OTW Steroid LV Lead capable provide permanent pace therapy leave ventricle CRT-D system . The follow specific objective evaluate post-approval registry : - Long-term effectiveness COROX OTW Steroid provide biventricular pace - Safety COROX OTW Steroid LV pace lead</brief_summary>
	<brief_title>COSMO Post Approval Registry : Corox OTW Steroid LV Lead Monitoring</brief_title>
	<detailed_description>This post approval registry enrol 221 patient 34 center . The collection registry data continue three year enrol subject . Potential patient screen enrol physician accord detailed inclusion exclusion criterion . The specific require visit registry : Enrollment , Three-month , Six month , One-year , Routine Follow-Ups ( every subsequent 6 month ) , Interim follow-ups Corox OTW Steroid LV lead relate visit , Out Service visit . Data collect patient follow-up . The programmed pacing parameter , LV pace impedance , LV pace threshold measurement 0.5ms pulse width obtain . The program parameter set best suit patient . If adequate system function , include effective CRT , obtain , patient select registry .</detailed_description>
	<mesh_term>Heart Failure</mesh_term>
	<criteria>Successfully implant BIOTRONIK CRTD system , include Corox OTW Steroid LV Lead , 130 day prior enrollment Able understand nature registry give inform consent Available followup visit regular basis investigational site Age great equal 18 year Enrolled another cardiovascular pharmacological clinical investigation Planned cardiac surgical procedure interventional measure within next 6 month Expected receive heart transplant within 6 month Life expectancy le 6 month Presence another lifethreatening , underlie illness separate cardiac disorder Pregnancy</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 2012</verification_date>
	<keyword>Congestive Heart Failure</keyword>
	<keyword>Cardiac Resynchronization Therapy</keyword>
	<keyword>Left Ventricular Lead</keyword>
</DOC>